J
John W. Hellstein
Researcher at University of Iowa
Publications - 39
Citations - 3242
John W. Hellstein is an academic researcher from University of Iowa. The author has contributed to research in topics: Osteonecrosis of the jaw & Medicine. The author has an hindex of 19, co-authored 35 publications receiving 3020 citations. Previous affiliations of John W. Hellstein include American Dental Association.
Papers
More filters
Journal ArticleDOI
Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws
TL;DR: Osteonecrosis of the jaws is strongly associated with the use of aminobisphosphonates, and the mechanism of disease is probably severe suppression of bone turnover, and possible mechanisms of etiopathogenesis are suggested.
Journal ArticleDOI
Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: Executive summary of recommendations from the American Dental Association Council on Scientific Affairs
John W. Hellstein,Robert A. Adler,Beatrice J. Edwards,Peter L. Jacobsen,John R. Kalmar,Sreenivas Koka,Cesar A. Migliorati,Helen Ristic +7 more
TL;DR: A narrative review of osteonecrosis of the jaw in patients with low bone mass receiving treatment with antiresorptive agents is based on an appraisal of the literature as discussed by the authors.
Journal ArticleDOI
Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?
John W. Hellstein,Cindy L. Marek +1 more
TL;DR: Bis-phossy jaw may have more of a bacterial cofactor risk than osteoradionecrosis, and though altered angiogenesis may yet prove to be a factor, avascularity does not appear to beA major cofactor.
Journal ArticleDOI
A comparison of the cleaning efficacy of short-term sonic and ultrasonic passive irrigation after hand instrumentation in molar root canals.
TL;DR: Passive sonic or ultrasonic irrigation, for as little as 30 s, resulted in significantly cleaner canals than hand filing alone, when sonic and ultrasonic passive irrigation were compared with only each other.
Journal ArticleDOI
Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs.
Beatrice J. Edwards,John W. Hellstein,Peter L. Jacobsen,Steven Kaltman,Angelo Mariotti,Cesar A. Migliorati +5 more
TL;DR: For patients receiving bisphosphonate therapy, the risk of developing bisph phosphonate-associated osteonecrosis of the jaw apparently remains low and it newly concludes that current screening and diagnostic tests are unreliable for predicting a patient'srisk of developing the condition.